| Akt | Ak strain transforming |
| AMPK | Monophosphate-activated protein kinase |
| Bcl | B-cell lymphoma |
| CCC | Clear-cell carcinoma |
| EC | Endometrioid carcinoma |
| ERK | Extracellular-signal-regulated kinase |
| HGSC | High-grade serous carcinoma |
| HSA | High single agent |
| IGF | Insulin growth factor |
| IGF-1 | Insulin-like growth factor 1 |
| IGF-1R | Insulin-like growth factor 1 receptor |
| IGFBP1 | Insulin-like growth factor binding protein 1 |
| IR | Insulin receptor |
| JAK1/2 | Janus kinases 1 and 2 |
| LGSC | Low-grade serous carcinoma |
| MAP | Mitogen-activated protein |
| mTOR | Mammalian target of rapamycin |
| OC | Ovarian cancer |
| PARP | Poly ADP ribose polymerase |
| PI3K | Phosphatidylinositol 3-kinase |
| RAF | Rapidly accelerated fibrosarcoma |
| siIGF-1 | siRNA of IGF-1 |
| siNEG | siRNA of negative control |
| STAT3 | Signal transducer and activator of transcription 3 |
| VEGFR | Vascular endothelial growth factor receptor |
| ZIP | Zero interaction potency |